BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 26652578)

  • 21. IL-3 and TNFα increase Thymic Stromal Lymphopoietin Receptor (TSLPR) expression on eosinophils and enhance TSLP-stimulated degranulation.
    Cook EB; Stahl JL; Schwantes EA; Fox KE; Mathur SK
    Clin Mol Allergy; 2012 Jul; 10(1):8. PubMed ID: 22838633
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thymic stromal lymphopoietin induces chemotactic and prosurvival effects in eosinophils: implications in allergic inflammation.
    Wong CK; Hu S; Cheung PF; Lam CW
    Am J Respir Cell Mol Biol; 2010 Sep; 43(3):305-15. PubMed ID: 19843704
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TSLP Produced by Aspergillus fumigatus-Stimulated DCs Promotes a Th17 Response Through the JAK/STAT Signaling Pathway in Fungal Keratitis.
    Han F; Guo H; Wang L; Zhang Y; Sun L; Dai C; Wu X
    Invest Ophthalmol Vis Sci; 2020 Dec; 61(14):24. PubMed ID: 33346778
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TSLPR deficiency attenuates atherosclerotic lesion development associated with the inhibition of TH17 cells and the promotion of regulator T cells in ApoE-deficient mice.
    Wu C; He S; Peng Y; Kushwaha KK; Lin J; Dong J; Wang B; Lin J; Shan S; Liu J; Huang K; Li D
    J Mol Cell Cardiol; 2014 Nov; 76():33-45. PubMed ID: 25117469
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TSLP Protects Corneas From Pseudomonas aeruginosa Infection by Regulating Dendritic Cells and IL-23-IL-17 Pathway.
    Cui X; Gao N; Me R; Xu J; Yu FX
    Invest Ophthalmol Vis Sci; 2018 Aug; 59(10):4228-4237. PubMed ID: 30128494
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thymic stromal lymphopoietin and IL-33 modulate migration of hematopoietic progenitor cells in patients with allergic asthma.
    Smith SG; Gugilla A; Mukherjee M; Merim K; Irshad A; Tang W; Kinoshita T; Watson B; Oliveria JP; Comeau M; O'Byrne PM; Gauvreau GM; Sehmi R
    J Allergy Clin Immunol; 2015 Jun; 135(6):1594-602. PubMed ID: 25656998
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TSLP signaling pathway map: a platform for analysis of TSLP-mediated signaling.
    Zhong J; Sharma J; Raju R; Palapetta SM; Prasad TS; Huang TC; Yoda A; Tyner JW; van Bodegom D; Weinstock DM; Ziegler SF; Pandey A
    Database (Oxford); 2014; 2014():bau007. PubMed ID: 24573880
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Murine allergic rhinitis and nasal Th2 activation are mediated via TSLP- and IL-33-signaling pathways.
    Akasaki S; Matsushita K; Kato Y; Fukuoka A; Iwasaki N; Nakahira M; Fujieda S; Yasuda K; Yoshimoto T
    Int Immunol; 2016 Feb; 28(2):65-76. PubMed ID: 26428949
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inflammatory cytokine TSLP stimulates platelet secretion and potentiates platelet aggregation via a TSLPR-dependent PI3K/Akt signaling pathway.
    Dong J; Lin J; Wang B; He S; Wu C; Kushwaha KK; Mohabeer N; Su Y; Fang H; Huang K; Li D
    Cell Physiol Biochem; 2015; 35(1):160-74. PubMed ID: 25591759
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A potential link between TSLP/TSLPR/STAT5 and TLR2/MyD88/NFκB-p65 in human corneal epithelial cells for Aspergillus fumigatus tolerance.
    Ren X; Wang L; Wu X
    Mol Immunol; 2016 Mar; 71():98-106. PubMed ID: 26874828
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional regulation of thymic stromal lymphopoietin on proliferation and invasion of trophoblasts in human first-trimester pregnancy.
    Wu HX; Guo PF; Jin LP; Liang SS; Li DJ
    Hum Reprod; 2010 May; 25(5):1146-52. PubMed ID: 20228393
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation of the surface expression of thymic stromal lymphopoietin receptor with the presence of CRLF2 gene rearrangements in children with B-lineage acute lymphoblastic leukemia.
    Demina I; Zerkalenkova E; Soldatkina O; Kazakova A; Semchenkova A; Goncharova M; Novichkova G; Maschan M; Karachunskiy A; Olshanskaya Y; Popov A
    Int J Lab Hematol; 2023 Jun; 45(3):337-343. PubMed ID: 36748719
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Upregulated thymic stromal lymphopoietin receptor expression in children with asthma.
    Lin SC; Huang JJ; Wang JY; Chuang HC; Chiang BL; Ye YL
    Eur J Clin Invest; 2016 Jun; 46(6):511-9. PubMed ID: 26999524
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thymic stromal lymphopoietin.
    He R; Geha RS
    Ann N Y Acad Sci; 2010 Jan; 1183():13-24. PubMed ID: 20146705
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Critical proinflammatory role of thymic stromal lymphopoietin and its receptor in experimental autoimmune arthritis.
    Hartgring SA; Willis CR; Dean CE; Broere F; van Eden W; Bijlsma JW; Lafeber FP; van Roon JA
    Arthritis Rheum; 2011 Jul; 63(7):1878-87. PubMed ID: 21391201
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In situ expression and serum level of thymic stromal lymphopoietin in oral lichen planus.
    Sun M; Tan W; Liu S; Liu G; Zhang X; Wang N; Qu X; Wei F
    J Oral Pathol Med; 2014 Nov; 43(10):740-5. PubMed ID: 24931732
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interleukin-32 induced thymic stromal lymphopoietin plays a critical role in the inflammatory response in human corneal epithelium.
    Lin J; Xu R; Hu L; You J; Jiang N; Li C; Che C; Wang Q; Xu Q; Li J; Zhao G
    Cell Signal; 2018 Sep; 49():39-45. PubMed ID: 29803543
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TSLP enhances the function of helper type 2 cells.
    Kitajima M; Lee HC; Nakayama T; Ziegler SF
    Eur J Immunol; 2011 Jul; 41(7):1862-71. PubMed ID: 21484783
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Additive Inflammatory In Vivo and In Vitro Effects of IL-7 and TSLP in Arthritis Underscore the Therapeutic Rationale for Dual Blockade.
    Hillen MR; Hartgring SA; Willis CR; Radstake TR; Hack CE; Lafeber FP; van Roon JA
    PLoS One; 2015; 10(6):e0130830. PubMed ID: 26110994
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TSLP promoting B cell proliferation and polarizing follicular helper T cell as a therapeutic target in IgG4-related disease.
    Lu H; Wu X; Peng Y; Sun R; Nie Y; Li J; Wang M; Luo Y; Peng L; Fei Y; Zhou J; Zhang W; Zeng X
    J Transl Med; 2022 Sep; 20(1):414. PubMed ID: 36076269
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.